IL1B and inflammatory bowel disease: It has been clearly demonstrated that the aberrant production of inflammatory cytokines, such as TNF-α, IL-1β and IL-6, often observed in the gut of patients with inflammatory bowel disease (IBD), is a consequence of deregulated NF-κB signaling cascade [19].